Viktor Wintzell

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case–control study

Erik Kadesjö, Jonas Söderling, Anders Hviid, Viktor Wintzell et autres

se, dk, no (code pays fourni par la source)

Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy

Peter Ueda, Henrik Svanström, Jonas K. Söderling, Laura Pazzagli et autres

BACKGROUND: There are concerns about a possible link between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION). OBJECTIVE: To examine whether use of GLP-1RAs increases risk for AION, which predominantly comprises NAION. DESIGN: Nationwide, register-based, cohort study. SETTING: …

se, dk (code pays fourni par la source)

Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden

Karl‐Hermann Sielinou Kamgang, Björn Pasternak, Johan Reutfors, Richeek Pradhan et autres

BACKGROUND: Data on antipsychotic use for the Swedish paediatric population is limited. OBJECTIVE: We assessed the incidence, likely indication and extent of off-label antipsychotic use among children and adolescents in Sweden. METHODS: In this nationwide register-based study, individuals younger than 18 years …

se, dk, au (code pays fourni par la source)

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Arvid Engström, Henrik Svanström, Anders Peter Hviid, Björn Eliasson et autres

AIMS: To investigate the association between use of GLP-1 receptor agonists and incident Parkinson's disease. MATERIAL AND METHODS: Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active-comparator, new-user design. We included 158 961 new users of …

se, dk, no, us (code pays fourni par la source)

Author response for "Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson’s Disease: Scandinavian Cohort Study"

Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson et autres

Utilisation of healthcare in children born to lymphoma survivors in Sweden

Joshua P.P. Entrop, Viktor Wintzell, Caroline E. Dietrich, Ingrid Cecilia Glimelius et autres

BACKGROUND AND PURPOSE: Advances in lymphoma treatment lead to a growing population of lymphoma survivors in childbearing ages who might be concerned about the impact of their disease on their children's health. In this study, we aim to explore healthcare utilisation patterns …

se, dk (code pays fourni par la source)

Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children

Viktor Wintzell, Philip Brenner, Linda Halldner, Samuel Rhedin et autres

Importance: Spontaneous reports have indicated that montelukast increases the risk of neuropsychiatric adverse events, and the US Food and Drug Administration added a boxed warning about these risks in 2020. However, the potential mechanism is not well understood, and the observational evidence …

se (code pays fourni par la source)

GLP-1 Receptor Agonist Use and Risk of Suicide Death

Peter Ueda, Jonas Söderling, Viktor Wintzell, Henrik Svanström et autres

Importance: Concerns have been raised regarding a link between use of glucagon-like peptide-1 (GLP-1) receptor agonists and increased risk of suicidality and self-harm. Objective: To assess the association between use of GLP-1 receptor agonists and the risk of suicide death in routine …

se, dk, no, us (code pays fourni par la source)

Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study

Arvid Engström, Jonas K. Söderling, Anders Peter Hviid, Björn Eliasson et autres

AIMS: To assess the comparative cardiovascular and renal effectiveness and safety of empagliflozin vs. dapagliflozin among patients with type 2 diabetes in routine clinical practice. METHODS AND RESULTS: Cohort study using data from nationwide registers in Sweden, Denmark, and Norway, from June …

se, dk, no, us (code pays fourni par la source)

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

Björn Pasternak, Viktor Wintzell, Anders Peter Hviid, Björn Eliasson et autres

OBJECTIVE: To investigate whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. DESIGN: Scandinavian cohort study. SETTING: Denmark, Norway, and Sweden, 2007-21. PARTICIPANTS: Patients who started GLP1 receptor agonist treatment were compared with patients …

dk, se, no, us (code pays fourni par la source)

TreeMineR: Tree-Based Scan Statistics

Joshua P.P. Entrop, Viktor Wintzell

Implementation of unconditional Bernoulli Scan Statistic developed by Kulldorff et al. (2003) <doi:10.1111/1541-0420.00039> for hierarchical tree structures. Tree-based Scan Statistics are an exploratory method to identify event clusters across the space of a hierarchical tree.

Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study

Karl‐Hermann Sielinou Kamgang, Samuel Rhedin, Catarina Almqvist, Viktor Wintzell

BACKGROUND: The potential association between the use of inhaled corticosteroids (ICS) and the risk of pneumonia among adults is disputed and paediatric-specific evidence is scarce. AIM: To assess the potential association between ICS, use and the risk of hospitalisation for pneumonia among …

se (code pays fourni par la source)